Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijbiomac.2021.06.035 http://scihub22266oqcxt.onion/10.1016/j.ijbiomac.2021.06.035 34116092!ä!34116092 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Biol+Macromol 2021 ; 185 (ä): 20-30 Nephropedia Template TP {{tp|p=34116092|t=2021. Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases |pdf=|usr=}}{{34116092}} gab.com Text Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases JO: Int J Biol Macromol http://www.kidney.de/pget.php?&tw=1&pmid=34116092 #FOAvip Chitosan-loaded nanomedicines provide a greater opportunity for the treatment of respiratory diseases. Natural biopolymer chitosan and its derivatives have a large number of proven pharmacological actions like antioxidant, wound healing, immuno-stimulant, hypocholesterolemic, antimicrobial, obesity treatment, anti-inflammatory, anticancer, bone tissue engineering, antifungal, regenerative medicine, anti-diabetic and mucosal adjuvant, etc. which attracted its use in the pharmaceutical industry. As compared to other polysaccharides, chitosan has excellent mucoadhesive characteristics, less viscous, easily modified into the chemical and biological molecule and gel-forming property due to which the drugs retain in the respiratory tract for a longer period of time providing enhanced therapeutic action of the drug. Chitosan-based nanomedicines would have the greatest effect when used to transport poor water soluble drugs, macromolecules like proteins, and peptides through the lungs. In this review, we highlight and discuss the role of chitosan and its nanomedicines in the treatment of chronic respiratory diseases such as pneumonia, asthma, COPD, lung cancer, tuberculosis, and COVID-19. Twit Text FOAVip Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases ????Int J Biol Macromol http://www.kidney.de/pget.php?&tw=1&pmid=34116092 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34116092 #FOAvip English Wikipedia <ref>{{Cite pmid|34116092}}</ref> Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases #MMPMID34116092 Gulati N; Dua K; Dureja H Int J Biol Macromol 2021[Aug]; 185 (ä): 20-30 PMID34116092show ga Chitosan-loaded nanomedicines provide a greater opportunity for the treatment of respiratory diseases. Natural biopolymer chitosan and its derivatives have a large number of proven pharmacological actions like antioxidant, wound healing, immuno-stimulant, hypocholesterolemic, antimicrobial, obesity treatment, anti-inflammatory, anticancer, bone tissue engineering, antifungal, regenerative medicine, anti-diabetic and mucosal adjuvant, etc. which attracted its use in the pharmaceutical industry. As compared to other polysaccharides, chitosan has excellent mucoadhesive characteristics, less viscous, easily modified into the chemical and biological molecule and gel-forming property due to which the drugs retain in the respiratory tract for a longer period of time providing enhanced therapeutic action of the drug. Chitosan-based nanomedicines would have the greatest effect when used to transport poor water soluble drugs, macromolecules like proteins, and peptides through the lungs. In this review, we highlight and discuss the role of chitosan and its nanomedicines in the treatment of chronic respiratory diseases such as pneumonia, asthma, COPD, lung cancer, tuberculosis, and COVID-19. |*COVID-19 Drug Treatment[MESH] |*Nanomedicine[MESH] |*SARS-CoV-2[MESH] |Animals[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19/*epidemiology[MESH] |Chitosan/*therapeutic use[MESH] |Drug Carriers/*therapeutic use[MESH]Role of chitosan based nanomedicines in the treatment of chronic respi(epmc).pdf DeepDyve Pubget Overpricing